Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA, Jazaeri A, Pettaway CA, Guadagnolo BA, Bishop AJ, Mitra D, Farooqi A, Bassett R, Faria S, Nagarajan P, Amaria RN.
Ho J, et al. Among authors: bishop aj.
Front Oncol. 2022 Oct 17;12:1001150. doi: 10.3389/fonc.2022.1001150. eCollection 2022.
Front Oncol. 2022.
PMID: 36324592
Free PMC article.